Treatments for coronary microvascular dysfunction based on the pathway identified by invasive coronary function testing
| Endothelial dysfunction |
| Angiotensin-converting enzyme inhibitor |
| Angiotensin receptor blocker |
| Statin |
| L-arginine |
| Cardiac rehabilitation |
| Enhanced external counterpulsation |
| Nonendothelial dysfunction |
| Angiotensin-converting enzyme inhibitor |
| Beta-blocker |
| Alpha-/beta-blocker |
| Ranolazine |
| Ivabradine |
| Phosphodiesterase-5 inhibitor |
| Vasospasm |
| Calcium channel blocker |
| Nitrate |
| Nociceptive abnormality |
| Tricyclic antidepressant |
| Spinal cord stimulation |
| Cognitive behavior therapy |